These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 125443

  • 1. Irreversible inhibition of Na-+ +K-+ -ATPase by strophanthidin 3,5-bid-p-benzoyl benzoate, a photochemical analogue of strophanthidin.
    Tobin T, Akera T, Brody TM, Taneja HR.
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):605-18. PubMed ID: 125443
    [Abstract] [Full Text] [Related]

  • 2. Cardiotonic site directed irreversible inhibition of Na+ + K+-ATPase by 3-azidoacetylstrophanthidin, a photochemical analogue of strophanthidin.
    Tobin T, Akera T, Brody TM, Taneja HR.
    Eur J Pharmacol; 1976 Jan; 35(1):69-76. PubMed ID: 130245
    [Abstract] [Full Text] [Related]

  • 3. Irreversible inhibition of 3H-ouabain binding to Na+ +K+ -ATPase by digoxigenin-3,12-dibromoacetate, an alkylating derivative of digoxigenin.
    Tobin T, Abramson H.
    Eur J Pharmacol; 1975 Jan; 32(02):243-50. PubMed ID: 125205
    [Abstract] [Full Text] [Related]

  • 4. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
    Tobin T, Akera T, Ku D, Lu MC.
    Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
    [No Abstract] [Full Text] [Related]

  • 5. Magnetic resonance and kinetic studies of the mechanism of membrane-bound sodium and potassium ion- activated adenosine triphosphatase.
    Grisham CM, Mildvan AS.
    J Supramol Struct; 1975 Sep; 3(3):304-13. PubMed ID: 171521
    [Abstract] [Full Text] [Related]

  • 6. Mercury binding site on Na+/K(+)-ATPase: a cysteine in the first transmembrane segment.
    Wang X, Horisberger JD.
    Mol Pharmacol; 1996 Sep; 50(3):687-91. PubMed ID: 8794911
    [Abstract] [Full Text] [Related]

  • 7. Cardiac sodium, potassium-adenosine triphosphatase as a possible site of adriamycin-induced cardiotoxicity.
    Solomonson LP, Halabrin PR.
    Cancer Res; 1981 Feb; 41(2):570-2. PubMed ID: 6256069
    [Abstract] [Full Text] [Related]

  • 8. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F, Mahmmoud YA.
    Biochemistry; 2009 Oct 27; 48(42):10056-65. PubMed ID: 19778013
    [Abstract] [Full Text] [Related]

  • 9. Active site-directed alkylation of Na+-K+-ATPase by digitalis sulphonate derivatives of different lipophilicity.
    Fricke U, Klaus W, Rogatti M.
    Br J Pharmacol; 1981 Jan 27; 72(1):25-9. PubMed ID: 6261865
    [Abstract] [Full Text] [Related]

  • 10. Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.
    Smith TW.
    J Clin Invest; 1972 Jun 27; 51(6):1583-93. PubMed ID: 4260123
    [Abstract] [Full Text] [Related]

  • 11. The cardiac glycoside receptor: its properties and its correlation to nucleotide binding sites, phosphointermediate, and (Na++K+)-ATPase activity.
    Erdmann E, Patzelt R, Schoner W.
    Recent Adv Stud Cardiac Struct Metab; 1976 Jun 27; 9():329-35. PubMed ID: 130661
    [Abstract] [Full Text] [Related]

  • 12. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
    Coughlin RT, Akera T, McGroarty EJ, Steinbach C.
    Mol Pharmacol; 1987 Jul 27; 32(1):147-53. PubMed ID: 3037299
    [Abstract] [Full Text] [Related]

  • 13. Cassaine: mechanism of inhibition of Na+ +K+ -ATPase and relationship of this inhibition to cardiotonic actions.
    Tobin T, Akera T, Brody SL, Ku D, Brody TM.
    Eur J Pharmacol; 1975 Jul 27; 32(02):133-45. PubMed ID: 125204
    [Abstract] [Full Text] [Related]

  • 14. Effect of lithium on regulation of two molecular forms of Na+,K(+)-ATPase in rat brain.
    Lakshmi GY.
    Indian J Exp Biol; 1989 Oct 27; 27(10):903-6. PubMed ID: 2561398
    [Abstract] [Full Text] [Related]

  • 15. Cardiac Na+, K+-adenosine triphosphatase inhibition by ouabain and myocardial sodium: a computer simulation.
    Akera T, Bennett RT, Olgaard MK, Brody TM.
    J Pharmacol Exp Ther; 1976 Nov 27; 199(2):287-97. PubMed ID: 135837
    [Abstract] [Full Text] [Related]

  • 16. Relationship between cardiotonic effects and inhibition on cardiac sarcolemmal Na+,K+-ATPase of strophan-thidin at low concentrations.
    Su SW, Wang YL, Li JX, Mei HS, Yin JX.
    Acta Pharmacol Sin; 2003 Nov 27; 24(11):1103-7. PubMed ID: 14627493
    [Abstract] [Full Text] [Related]

  • 17. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
    Nechay BR, Saunders JP.
    J Environ Pathol Toxicol; 1978 Nov 27; 2(2):247-62. PubMed ID: 216760
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of potassium on ouabain binding to native and site-directed mutants of Na,K-ATPase.
    Johnson CL, Schultheis PJ, Lingrel JB, Johnson CG, Wallick ET.
    Arch Biochem Biophys; 1995 Feb 20; 317(1):133-41. PubMed ID: 7872775
    [Abstract] [Full Text] [Related]

  • 19. Kinetic studies on inhibition of dog heart Na+,K+-dependent ATPase by K+,Mg2+-aspartate: comparison with ouabain.
    Fedelesová M, Dzurba A, Ziegelhöffer A.
    Recent Adv Stud Cardiac Struct Metab; 1975 Feb 20; 5():375-85. PubMed ID: 127359
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B, Oishi K, Shoji M, Eibl H, Berdel WE, Hajdu J, Vogler WR, Kuo JF.
    Cancer Res; 1990 May 15; 50(10):3025-31. PubMed ID: 2159369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.